Valuation United Therapeutics Corporation

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2026-01-20 EST			5-day change	1st Jan Change
468.07 ^USD	+0.68%		-1.84%	-3.94%

01-15	United Therapeutics Insider Sold Shares Worth $3,900,122, According to a Recent SEC Filing	MT
01-12	United Therapeutics Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 01:30 PM

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	6,746	9,731	12,674	10,333	15,752	20,154	20,154	-
Change	-	44.26%	30.24%	-18.47%	52.44%	27.94%	0%	-
Enterprise Value (EV) ¹	5,711	9,637	12,513	8,039	12,785	17,084	15,761	14,514
Change	-	68.75%	29.85%	-35.75%	59.04%	33.62%	-7.74%	-7.91%
P/E ratio	13.2x	21.5x	18.5x	11.1x	14.3x	17.3x	16.4x	15.2x
PBR	1.99x	2.67x	2.67x	1.73x	2.47x	2.49x	2.07x	1.8x
PEG	-	-1.7x	0.4x	0.3x	0.6x	1.81x	2.79x	1.99x
Capitalization / Revenue	4.55x	5.77x	6.55x	4.44x	5.47x	6.29x	5.95x	5.39x
EV / Revenue	3.85x	5.72x	6.46x	3.45x	4.44x	5.33x	4.66x	3.88x
EV / EBITDA	8.87x	15.9x	12.1x	6.49x	8.82x	10.8x	9.57x	8.05x
EV / EBIT	9.62x	17.3x	12.8x	6.78x	9.28x	11.2x	9.8x	8.25x
EV / FCF	8.2x	20.2x	18.9x	10.8x	11.8x	13.3x	12x	10.4x
FCF Yield	12.2%	4.95%	5.3%	9.3%	8.45%	7.52%	8.32%	9.61%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	11.54	10.06	15	19.81	24.64	27	28.59	30.77
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	1,483	1,686	1,936	2,328	2,877	3,203	3,386	3,737
EBITDA ¹	643.5	605.8	1,031	1,238	1,450	1,587	1,647	1,803
EBIT ¹	593.6	555.9	979.7	1,185	1,377	1,532	1,608	1,760
Net income ¹	514.8	475.8	727.3	984.8	1,195	1,297	1,356	1,481
Net Debt ¹	-1,035	-94.8	-161.2	-2,294	-2,967	-3,070	-4,392	-5,640
Reference price ²	151.79	216.08	278.09	219.89	352.84	468.07	468.07	468.07
Nbr of stocks (in thousands)	44,441	45,037	45,577	46,994	44,645	43,057	43,057	-
Announcement Date	2/24/21	2/24/22	2/22/23	2/21/24	2/26/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
UNITED THERAPEUTICS CORPORATION	17.34x	5.33x	10.77x	-.--%	20.15B
ELI LILLY AND COMPANY	45.4x	15.04x	33.53x	0.57%	932B
JOHNSON & JOHNSON	21.3x	5.88x	16.33x	2.37%	526B
ABBVIE INC.	60.77x	7.13x	17.1x	3.06%	378B
ROCHE HOLDING AG	20.32x	5.04x	12.55x	2.86%	374B
ASTRAZENECA PLC	27.91x	5.2x	15.4x	1.78%	282B
NOVARTIS AG	20.21x	5.37x	12.59x	2.83%	278B
NOVO NORDISK A/S	16.86x	5.96x	12.33x	2.99%	272B
MERCK & CO., INC.	14.02x	4.6x	9.89x	2.95%	272B
AMGEN INC.	25.87x	6.13x	10.5x	2.89%	178B
Average	27.00x	6.57x	15.10x	2.23%	351.2B
Weighted average by Cap.	31.59x	8.18x	19.07x	2.11%